# PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI

> **NCT00534859** · PHASE2 · COMPLETED · sponsor: **Abiomed Inc.** · enrollment: 28 (actual)

## Conditions studied

- Patients Undergoing High Risk PCI.

## Interventions

- **DEVICE:** High Risk PCI

## Key facts

- **NCT ID:** NCT00534859
- **Lead sponsor:** Abiomed Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2010-06
- **Final completion:** 2011-03
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2011-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00534859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00534859, "PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00534859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*